Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

Cyclophosphamide 24 fludarabine phosphate 18 Whole-Body Irradiation 17 fludarabine 16 Mycophenolic Acid 16 Tacrolimus 12 Peripheral Blood Stem Cell Transplantation 12 Busulfan 12 Melphalan 11 apixaban 10 Biopsy 7 Rivaroxaban 6 Granulocyte Colony-Stimulating Factor 6 Specimen Handling 5 Filgrastim 5 Cyclosporine 5 Azacitidine 5 thymoglobulin 4 X-Rays 4 Sirolimus 4 Rituximab 4 Injections 4 Enoxaparin 4 Decitabine 4 Bone Marrow Transplantation 4 Aspirin 4 Antilymphocyte Serum 4 venetoclax 3 pegylated granulocyte colony-stimulating factor 3 hetrombopag 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Tazobactam × Classical hematology × 1 year × Clear all

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡